Meet our team - John Russert
Global Sales & Marketing Professional | Pharmaceuticals • Infusion Systems • Medical Devices Strategic Advisor
- Award-Winning Medical Device Sales Leader – Recognized as Owen Mumford Sales Person of the Year (2023–2024) for driving GPO compliance, training clinical teams, and securing conversions at major hospital systems including Sanford Health, SSM, Gundersen Health, and Northwestern.
- Market Expansion Strategist – Spearheaded adoption of safety pen needles, capillary lancets, and neonatal incision devices across a 13-state Midwest territory and Canada, delivering measurable clinical and economic benefits to healthcare providers.
- Specialty Infusion Growth Expert – At RMS Medical (KORU), achieved +73% growth in infusion needles and +23% in tubing versus an 18% company benchmark, placing 360 new devices across national accounts in acute and non-acute care.
- Long-Term Pharmaceutical Sales Success – At Abbott/Hospira/Pfizer, grew territory sales from $2.4M to $5.7M, ranked #1 in District and #4 Nationally in 2014, and secured the Sapphire Closer Award as the first representative to win a major ambulatory infusion device order.
- Product Launch & Training Specialist – Successfully launched specialty injectable drugs, infusion devices, and ambulatory pumps, while training physicians, nurses, and pharmacists on both economic and clinical benefits to optimize adoption.
- Cross-Border Business Builder – Expanded international distribution for ophthalmic and specialty surgical devices by training distributors in Europe, Canada, and South America, significantly increasing product penetration.
- Clinical Value Advocate – Consistently promoted the economic and patient outcome advantages of injectables and medical devices, ensuring adoption by decision-makers across hospitals, long-term care, oncology centers, and home infusion pharmacies.
- Versatile Healthcare Sales Executive – Leveraged experience across devices, injectables, nutritionals, and laboratory products, serving both multinationals and start-ups, and demonstrating adaptability to deliver sustained growth and profitability.